OUR SCIENCE

Engineered for Greater Impact

NeuParadigmBio is developing innovative biologic therapies for retinal diseases through advanced molecular engineering and translational science.

Our modular platform is designed specifically for the eye, providing differentiated therapeutic opportunities from a common scientific framework. This enables the development of biologics with the potential for enhanced efficacy, improved durability, and meaningful clinical benefit.